Table 1

Baseline characteristics in the T-group and the untreated group

T-group(n = 229)Untreated group(n = 87)P value between groups
Baseline age (years)58.2 ± 9.666.4 ± 7.2<0.0001
Mean follow-up (years)6.6 ± 2.25.6 ± 1.6
Median follow-up (years)86
Anthropometric parameters
 Weight (kg)96.5 ± 12.492.9 ± 10.4<0.05
 Waist circumference (cm)104.2 ± 7.0101.1 ± 9.9<0.005
 BMI (kg/m2)30.7 ± 4.129.8 ± 3.0NS
 Waist:height ratio0.58 ± 0.040.57 ± 0.05<0.01
Glycemic control
 HbA1c (%)5.9 ± 0.25.9 ± 0.2NS
 Fasting glucose (mmol/L)5.3 ± 0.84.9 ± 1.3<0.005
 Triglyceride:HDL ratio6.5 ± 2.74.1 ± 2.5<0.0001
 TyG index9.3 ± 0.48.9 ± 0.6<0.0001
 LAP (cm ⋅ mmol/L)110 ± 42.179.1 ± 56.5<0.0001
Lipids
 Total cholesterol (mmol/L)6.9 ± 1.26.4 ± 1.4<0.0005
 HDL cholesterol (mmol/L)1.1 ± 0.31.4 ± 0.4<0.0001
 LDL cholesterol (mmol/L)4.1 ± 0.73.4 ± 0.9<0.0001
 Triglycerides (mmol/L)2.8 ± 0.92.2 ± 1.1<0.0001
 Non-HDL cholesterol (mmol/L)5.8 ± 1.25.0 ± 1.4<0.0001
SBP (mmHg)136.9 ± 13.5129.8 ± 12.7<0.0001
DBP (mmHg)81.2 ± 8.984.7 ± 6.7<0.001
Heart rate (beats/min)76.8 ± 3.676.8 ± 5.0NS
Concomitant medication at baseline
 Statins31 (13.5)19 (22.9)<0.05
 Antihypertensives12 (22.2)4 (4.8)<0.01
Quality of life
 AMS score52.2 ± 9.239.3 ± 7.4<0.0001
 International Index of Erectile Function, Erectile Function Domain11.4 ± 5.610.9 ± 5.8NS
Total testosterone (nmol/L)8.2 ± 2.19.6 ± 2.4<0.0001
  • Data are means ± SE or n (%) unless otherwise indicated.